I learned from my own experience that both in academia and pharmaceutics, prompt identification and selection of an adequate database is very important. In an academic setting, analyzing data from registries is particularly of great advantage in countries with limited financial resources for research which requires significant investment. In pharmaceuticals there is an increasing request from regulatory authorities for companies to conduct post-authorization safety studies. B.R.I.D.G.E. TO DATA (BTD) contains detailed descriptions of databases from more than 70 countries, including descriptions of pregnancy registries. It is impressive that using BTD one can find information on databases even from small countries.

The number of databases featured [in B.R.I.D.G.E. TO DATA] continues to grow at a rapid pace, and each profile is complete. This easy-to-use service gives the best snapshot information about health-related databases. It’s easy to compare databases based on numerous criteria. The B.R.I.D.G.E. staff is extremely helpful in helping you navigate the site for your specific research questions.

B.R.I.D.G.E. TO DATA has been very helpful for initial screening data sources for a potential epi study. It provides broad, thorough, and detailed information on each database listed in the system.  It has been a wonderful tool to have, especially for feasibility evaluation.